RecruitingNot ApplicableNCT04536480

Time Limited Eating in Adolescents With Type 2 Diabetes (KT2D)


Sponsor

Children's Hospital Los Angeles

Enrollment

100 participants

Start Date

Apr 15, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

To find the effectiveness of a diet plan (Time Limited Eating or TLE) on glycemic control, B-cell function, body fat, and body mass index (BMI) in adolescents with type 2 diabetes.


Eligibility

Min Age: 12 YearsMax Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether time-restricted eating (limiting meals to a set window of time each day) can help teenagers and young adults with type 2 diabetes better manage their blood sugar. **You may be eligible if...** - You are between 12 and 21 years old with a diagnosis of type 2 diabetes - You are at Tanner stage III or above (mid-to-late puberty or beyond) - Your HbA1c (a 3-month blood sugar average) is below 9% - You are willing and able to follow the eating schedule and attend study visits **You may NOT be eligible if...** - You have been diagnosed with Prader-Willi Syndrome, a brain tumor, or hypothalamic obesity - You have a serious intellectual or developmental disability - You have a history of an eating disorder (anorexia, bulimia, or binge-eating disorder) - Your parent or guardian is unwilling to participate in the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALTime Limited Eating

The TLE intervention arm will involve instructing participants to consume their usual kind and amount of food and beverages (all calories) within a pre-specified 8-hour period, fasting for the remaining 16-hours. They will be free to divide their food and beverage intake into as many meals or snacks as desired during the 8-hour period. Participants will be allowed to consume non-caloric beverages (water, tea, coffee) during the fasting period. No energy restriction will be required.

BEHAVIORALComponents Common to All Study Arms.

All participants will receive two hours of standard nutrition counseling recommended for adolescents living with T2D. No specific caloric restriction will be recommended. All participants will maintain their usual lifestyle, including physical activity and sleep patterns. Physical activity and sleep recommendations consistent with the American Academy of Pediatrics guidelines for adolescents will be encouraged but not formally prescribed.

BEHAVIORALControl

Participants assigned to the control arm will be instructed to consume food over a 12-h or more eating window. No energy restriction will be required.

DEVICEContinuous Glucose Monitor

All participants will be trained to wear a blinded continuous glucose monitor sensor using manufacturer educational materials under the supervision of research staff. Participants will be asked to wear the CGM for the duration of the study. During each study visit, the CGM reader will be connected to the site database to create an individual participant report. Participants will be provided enough sensors to replace the sensor every 14 days. The participants and guardians will be educated on how to use the CGM and receive 1:1 coaching on how to change the sensor, which will be completed either independently or under study team guidance. At each weekly phone meeting, study staff will monitor any challenges related to CGM wear, including participant discomfort, skin adherence, and other issues.


Locations(1)

Children's Hospital of Los Angeles

Los Angeles, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04536480


Related Trials